BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
September 09, 2024 16:05 ET
|
BioCardia, Inc.
SUNNYVALE, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
August 30, 2024 08:00 ET
|
BioCardia, Inc.
SUNNYVALE, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
BioCardia Announces Participation at the A.G.P. Biotech & Specialty Pharma Conference October 13, 2021 (Virtual Conference)
October 06, 2021 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular...
CORRECTION: Apple Growth Partners Announces Promotions, Top 300 Consecutive Ranking
August 12, 2021 12:30 ET
|
Apple Growth Partners
Akron, OH, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Correction - A previous version had the wrong title listed for Eric Flickinger. The correct promotion title is Eric Flickinger, CPA, ABV, senior manager....
Apple Growth Partners Announces Promotions, Top 300 Consecutive Ranking
August 12, 2021 09:00 ET
|
Apple Growth Partners
Akron, OH, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Apple Growth Partners (AGP), award-winning accounting and business advisory firm, has announced staff promotions effective July 1. Six employees earned...